Clinical trial Recruiting at 1 site Observational Ages Any age to 45 Women only

Understanding Mullerian Anomalies and Their Treatment

Official title: Diagnostic, Therapeutic and Reproductive Aspects of Patients With Mullerian Anomalies: a Prospective Cohort

Run by University Hospital, Ghent · NCT04627818 · Data updated 2026-11-12

This study is trying to learn more about rare reproductive system conditions in women to see how they affect fertility and if new diagnostic tools and surgeries can help improve treatment.

Quick facts

Study typeObservational
AgesAny age to 45 Years
SexWomen only
Enrollment1500 (estimated)
SponsorUniversity Hospital, Ghent
Academic / other
Locations1 site (Ghent)
StatusRecruiting
StartedJanuary 1, 2021
Main results expectedDecember 31, 2050
Study endsDecember 31, 2050
Registry record updatedJuly 30, 2026
Trial IDNCT04627818 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are women under 45 years old who have a uterus and a diagnosed Mullerian anomaly.

Probably not a fit

Patients without a uterus or those over the age of 45 may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to enhance the understanding of Mullerian anomalies, which are rare congenital conditions affecting the female reproductive system. It focuses on identifying the clinical implications, including reproductive issues and obstetric complications, associated with these anomalies. The study also seeks to evaluate the effectiveness of improved diagnostic tools and minimally invasive surgical treatments that may help preserve and enhance fertility in affected women. By gathering comprehensive data, the study hopes to provide insights that can lead to better management of these conditions.

Why it matters

Potential benefit: If successful, this study could lead to improved diagnostic and treatment options for women with Mullerian anomalies, enhancing their reproductive health.

How similar studies have gone: While Mullerian anomalies are rare, previous studies have shown that improved diagnostic and surgical approaches can lead to better outcomes, suggesting potential success for this study's objectives.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* women with a uterus
* presence of a mullerian variation
* Maximum age 45y

Exclusion Criteria:

* women without a uterus
* aged \>45y

Where it's running

  • Ghent University hospital
    Ghent, Belgium
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.